New CMS TCET Rule Likely Won’t Hasten Medicare Coverage of Breakthrough Devices
Recently proposed rule seems too stringent to reduce the lag between FDA approval and Medicare coverage.
CMS-nir
Subscribe today for access to
Articles and Reports
Proposed Rule Puts Labs at Greater Risk of FCA Liability
CMS recently proposed a rule that would make the False Claims Act rule the standard for overpayments under the Affordable Care Act regulations.
CMS Proposes Modest Increase to Hospital IPPS Rates
Unsurprisingly, the American Hospital Association and other industry groups don’t think that increase is anywhere near adequate.
CLIA: CMS Issues Guidance on How Labs Should Perform Coronavirus Testing
...
Already a member? Log in here
By the Numbers: Improper Medicare Payments Hit 10-Year Low
...
Already a member? Log in here
PAMA: The New LAB Act Buys Labs One Year of Price Reporting Relief
...
Already a member? Log in here
Genetic Testing: CMS Proposes Expanding NGS Testing Eligibility
...
Already a member? Log in here
CLIA: CMS Revises State Operations Manual for Labs
...
Already a member? Log in here
Hospital Labs: CMS Pushes Forward with Controversial Price Transparency Rules
...
Already a member? Log in here
The Year in Labs Regulation: The 6 Biggest Stories of 2019
"May you live...
Medicare Reimbursement: CMS Eases Coverage Restrictions on NGS Testing of Early-Stage Cancer Patients
...
Already a member? Log in here
Newly Proposed CMS Hospital Transparency Rules & their Impact on Labs
From - National Intelligence Report
It's an all too common occurrence. You or a loved one require an in-hospital procedure, but you have no idea of what the…
FDA Watch: Agency Okays EIA Technology-Based Lyme Assays
From - National Intelligence Report
Laboratory diagnosis of Lyme disease is based on detecting the presence of antibodies against…